Page 5 - Aditxt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an...

28.12.2021 - Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Aditxt Inc. (NASDAQ: ADTX) and AiPharma Global Holdings LLC is fair to Aditxt shareholders. Halper Sadeh encourages Aditxt shareholders to click here to ...

01.12.2021 - Aditxt, Inc. (“Aditxt”, or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the pricing of an underwritten public offering of 16,575,000 units, consisting of ... Seite 1

Share this article Share this article MOUNTAIN VIEW, Calif. and RICHMOND, Va., May 3, 2021 /PRNewswire/ -- Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity AditxtScore™ Center in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction. The announcement was made at a joint pres...

Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer News provided by Share this article Share this article MOUNTAIN VIEW, Calif., April 13, 2021 /PRNewswire/ -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Sunny Uberoi has joined the organization as its Chief Communications Officer. Uberoi joins Aditxt to raise the company's profile in advance of initiating its first-in-human clinical trials and support the rapid scaling of AditxtScore, a co...